92 related articles for article (PubMed ID: 17201155)
1. Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer.
Cabibi D; Mustacchio V; Martorana A; Tripodo C; Campione M; Calascibetta A; Sanguedolce R; Aragona F
Anticancer Res; 2006; 26(6B):4357-60. PubMed ID: 17201155
[TBL] [Abstract][Full Text] [Related]
2. Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients.
Cabibi D; Calascibetta A; Martorana A; Campione M; Barresi E; Rausa L; Aragona F; Sanguedolce R
Anticancer Res; 2007; 27(4B):2227-30. PubMed ID: 17695507
[TBL] [Abstract][Full Text] [Related]
3. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
[TBL] [Abstract][Full Text] [Related]
4. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
[TBL] [Abstract][Full Text] [Related]
5. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
Koda M; Sulkowski S; Kanczuga-Koda L; Surmacz E; Sulkowska M
Oncol Rep; 2004 Apr; 11(4):753-9. PubMed ID: 15010868
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor.
Buxant F; Anaf V; Simon P; Fayt I; Noël JC
Breast Cancer Res Treat; 2002 Sep; 75(1):1-3. PubMed ID: 12500929
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
Brown RW; Allred CD; Clark GM; Osborne CK; Hilsenbeck SG
Clin Cancer Res; 1996 Mar; 2(3):585-92. PubMed ID: 9816207
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
[TBL] [Abstract][Full Text] [Related]
10. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
[TBL] [Abstract][Full Text] [Related]
11. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
[TBL] [Abstract][Full Text] [Related]
12. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
Li J; Gromov P; Gromova I; Moreira JM; Timmermans-Wielenga V; Rank F; Wang K; Li S; Li H; Wiuf C; Yang H; Zhang X; Bolund L; Celis JE
Proteomics; 2008 Dec; 8(23-24):5038-52. PubMed ID: 19003862
[TBL] [Abstract][Full Text] [Related]
13. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.
Beatty JD; Precht LM; Lowe K; Atwood M
Am J Surg; 2009 May; 197(5):637-41; discussion 641-2. PubMed ID: 19321159
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies of K1-67 expression between the primary tumor and breast cancer metastases to regional lymph nodes].
Koda M; Jarzabek K; Kańczugakoda L; Przystupa W; Tomaszewski J; Sulkowska M; Wołczyński S; Sulkowski S
Ginekol Pol; 2003 Sep; 74(9):754-60. PubMed ID: 14674120
[TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
[TBL] [Abstract][Full Text] [Related]
17. MCM-2, Ki-67 and PCNA protein expressions in pT3G2 colorectal cancer indicated lymph node involvement.
Guzińska-Ustymowicz K; Stepień E; Kemona A
Anticancer Res; 2008; 28(1B):451-7. PubMed ID: 18383884
[TBL] [Abstract][Full Text] [Related]
18. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
19. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
[TBL] [Abstract][Full Text] [Related]
20. Isolated tumor cells in breast cancer sentinel lymph nodes: displacement or metastases? An immunohistochemical study.
van Deurzen CH; de Bruin PC; Koelemij R; Hillegersberg R; van Diest PJ
Hum Pathol; 2009 Jun; 40(6):778-82. PubMed ID: 19200573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
